Dasatinib+Quercetin (D+Q) inhibit multiple BCL-2 family pro-survival proteins and tyrosine kinasesbroad-mechanism senolytics with human clinical trial data (Mayo Clinic studies)
And yes, this was done in rats, not humans
Despite this, the equity dimension of road safety including within the Safe System approach remains underexplored
The publication, A Novel, Widespread Impurity in Mass-Compounded Tirzepatide/B12 Products, is available here
Its gastric stability makes it particularly suited for GI research, though human clinical evidence is currently absent
We offer BPC 157 in its optimal lyophilised form, requiring precise reconstitution for research use